A synthetic peptide for use as a blocking control in assays to test for specificity of GP9 antibody, Alternative Names: GP9 control peptide, GP9 antibody Blocking Peptide, Anti-GP9 Blocking Peptide, glycoprotein IX, platelet Blocking Peptide, CD42a Blocking Peptide, GPIX Blocking Peptide, GP9, GP-9, GP 9, GP-9 Blocking Peptide, GP 9 Blocking Peptide
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
CD42a (GP9)
(Glycoprotein IX (Platelet) (GP9))
Hintergrund
This gene encodes a small membrane glycoprotein found on the surface of human platelets. It forms a 1-to-1 noncovalent complex with glycoprotein Ib, a platelet surface membrane glycoprotein complex that functions as a receptor for von Willebrand factor. The complete receptor complex includes noncovalent association of the alpha and beta subunits with the protein encoded by this gene and platelet glycoprotein V. Defects in this gene are a cause of Bernard-Soulier syndrome, also known as giant platelet disease. These patients have unusually large platelets and have a clinical bleeding tendency.